Insights

Establishing a commercial footprint in Europe is a great approach for companies with global ambition. The European market presents unique challenges, which non-EU companies may not have experienced, so is often seen as a complex environment to enter.

Although there are challenges to enter the market the rewards are there for companies who understand their markets and utilise European expertise to navigate them, such as Gilead which is now one of the world’s biggest pharma companies.

Many US and Asian companies enlist local European support to traverse the landscape which combines centralised EU bodies and individual countries, who have their own unique processes for regulation, market access and pricing, to produce a diverse market with individual needs.

There are many steps to self-commercialisation and they require deep expertise in the European market to execute:

• Opportunity assessment

• Go-To-Market model

• Assess and design launch planning

• Affiliate establishment

• Ongoing regional support

Contact us to understand how we could help you establish yourself in Europe: info@novasecta.com

Discover how strategic collaborations and partnerships can be an alternative route into Europe

Download our White Paper to explore European entry from a US Biotech’s perspective

Share

To receive details of new white papers and events please enter your details below

Click here if you would like to receive emails from us. Read our privacy policy

Newsletter Signup